EUCTR2007-000907-13-AT进行中（未招募）不适用
The impact of Rimonabant in overweight women with prior gestational diabetes - RIGD
MUW, Innere Med III, Abt.für Endokrinologie & Stoffwechsel0 个研究点开始时间: 2007年10月29日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •-Age: 20-50 years
- •-Prior gestational diabetes
- •-BMI: BMI > 30 kg/m² OR BMI > 27 kg/m² if dyslipidemia or diabetes/pre-diabetes are present.
- •-Metabolism: prediabetes (IFG: fasting glucose > 100 mg/dl , but < 126 mg/dl AND/OR IGT: 2h glucose/oGTT > 140 mg/dl, but < 200 mg/dl) or diabetes (Fasting glucose > 126 mg/dl; 2h glucose/oGTT > 200 mg/dl)
- •(WHO criteria)
- •-Lipids: HDL cholesterol < 50 mg/dl or triglycerides > 150 mg/dl
- •-Metabolic syndrome (WHO criteria)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Kidney or liver disease
- •-Any chronic disease
- •-Acute or chronic inflammatory disease
- •-Psychiatric disorder (Depressio!)
- •-Lactation
研究者
相似试验
进行中（未招募）
不适用
Effects of rimonabant (Acomplia) on obesity in adults with Prader-Willi SyndromeObese adults with Prader Willi SyndromeMedDRA version: 9.1Level: LLTClassification code 10036476Term: Prader-Willi syndromeMedDRA version: 9.1Level: LLTClassification code 10029883Term: ObesityEUCTR2007-006305-25-SEKarolinska University Hospital
尚未招募
不适用
Walking for Exercise and Nutrition to prevent Diabetes for You (Wendy)ACTRN12611000075987Ann Peacock102
已完成
3 期
Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese PatientsEating DisordersObesityNCT00481975Sanofi289
已完成
不适用
Effects of berry fruits on appetite and food intake: targeting the colonic brake for weight lossACTRN12615001301550Plant and Food Research20
进行中（未招募）
1 期
European Trial about Effect of RimoNabant on Abdominal obese patients with dysLipidemiaabdominally obese patients with dyslipidemia with or without other comorbiditiesMedDRA version: 8.1 Level: LLT Classification code 10059179 Term: Abdominal obesityEUCTR2006-001715-30-GBsanofi aventis Groupe1,440